Clinical Trial Update: Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD

View source ↗

Summary

A completed clinical trial evaluating the usefulness of serum leucine-rich alpha-2 glycoprotein (LRG) levels as a biomarker in inflammatory bowel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: Showa Inan General Hospital | Conditions: LRG Levels | Status: COMPLETED